Cobots are transforming the pharmaceutical industry by offering solutions that combine precision, efficiency, and safety. These robots work side by side with employees, automating repetitive tasks and reducing human errors, which is crucial in an environment where precision is vital.
The global pharmaceutical robots market size was valued at USD 142.88 million in 2020 and is projected to reach USD 297.38 million by 2028, expanding at a compound annual growth rate (CAGR) of 9.1% during the period of 2021-2028. This growth is attributed to the increasing need for automation in manufacturing plants and the high cost of new drug discovery, according to data from Growth Market Reports.
Leading companies such as Pfizer, Johnson & Johnson, and Roche are already implementing cobots in their production lines. These robots not only enhance productivity but also ensure a safer work environment by taking on tasks that may be dangerous or ergonomically challenging for humans.